GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Additional Paid-In Capital

PuriBlood Medical Co (ROCO:6847) Additional Paid-In Capital : NT$38.9 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Additional Paid-In Capital?


PuriBlood Medical Co's quarterly additional paid-in capital declined from Dec. 2023 (NT$177.8 Mil) to Jun. 2024 (NT$38.9 Mil) but then stayed the same from Jun. 2024 (NT$38.9 Mil) to Dec. 2024 (NT$38.9 Mil).

PuriBlood Medical Co's annual additional paid-in capital stayed the same from Dec. 2022 (NT$177.8 Mil) to Dec. 2023 (NT$177.8 Mil) but then declined from Dec. 2023 (NT$177.8 Mil) to Dec. 2024 (NT$38.9 Mil).


PuriBlood Medical Co Additional Paid-In Capital Historical Data

The historical data trend for PuriBlood Medical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co Additional Paid-In Capital Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial 99.57 177.83 177.83 177.83 38.86

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 177.83 177.83 177.83 38.86 38.86

PuriBlood Medical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

PuriBlood Medical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines